Müllerian intra-abdominal carcinomatosis in hereditary breast ovarian cancer syndrome: implications for risk-reducing surgery (Q38732720)

5 September 2017

title

Müllerian intra-abdominal carcinomatosis in hereditary breast ovarian cancer syndrome: implications for risk-reducing surgery (English)

1 reference

hereditary breast ovarian cancer

5 September 2017

1 reference

1 reference

Murray Joseph Casey

1

1 reference

5 September 2017

Agnes B Colanta

series ordinal

2

1 reference

5 September 2017

publication date

13 February 2016

1 reference

5 September 2017

1 reference

5 September 2017

volume

15

1 reference

5 September 2017

issue

3

1 reference

5 September 2017

page(s)

371-384

1 reference

Hereditary factors in cancer. Study of two large midwestern kindreds

5 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007/S10689-016-9878-4

The cancer-family syndrome: a pragmatic basis for syndrome identification

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10689-016-9878-4

Cancer risk in mutation carriers of DNA-mismatch-repair genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10689-016-9878-4

Cancer risk in mismatch repair gene mutation carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10689-016-9878-4

Hereditary colorectal cancer syndromes: molecular genetics, genetic counseling, diagnosis and management.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10689-016-9878-4

The risk of extra-colonic, extra-endometrial cancer in the Lynch syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10689-016-9878-4

Colorectal cancer due to deficiency in DNA mismatch repair function: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10689-016-9878-4

Tumor Variation in Families With Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10689-016-9878-4

Familial association of breast/ovarian carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10689-016-9878-4

Hereditary ovarian cancer. Pedigree studies, Part II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10689-016-9878-4

Linkage of early-onset familial breast cancer to chromosome 17q21

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10689-016-9878-4

A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10689-016-9878-4

Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10689-016-9878-4

Identification of the breast cancer susceptibility gene BRCA2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10689-016-9878-4

Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10689-016-9878-4

Meta-analysis of BRCA1 and BRCA2 penetrance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10689-016-9878-4

Familial peritoneal ovarian carcinomatosis: a new clinical entity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10689-016-9878-4

Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10689-016-9878-4

Pathology of ovarian cancers in BRCA1 and BRCA2 carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10689-016-9878-4

Peritoneal carcinoma in women with genetic susceptibility: implications for Jewish populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10689-016-9878-4

Ovarian low-grade and high-grade serous carcinoma: pathogenesis, clinicopathologic and molecular biologic features, and diagnostic problems

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10689-016-9878-4

Ovarian carcinoma in situ with germline BRCA1 mutation and loss of heterozygosity at BRCA1 and TP53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10689-016-9878-4

Embryology of the Female Reproductive Tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10689-016-9878-4

Histopathological characteristics of BRCA1- and BRCA2-associated intraperitoneal cancer: a clinic-based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10689-016-9878-4

Phenotypic heterogeneity of hereditary gynecologic cancers: a report from the Creighton hereditary cancer registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10689-016-9878-4

Six families prone to ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10689-016-9878-4

Molecular evidence linking primary cancer of the fallopian tube to BRCA1 germline mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10689-016-9878-4

Occult cancer of the fallopian tube in BRCA-1 germline mutation carriers at prophylactic oophorectomy: a case for recommending hysterectomy at surgical prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10689-016-9878-4

Pathologic findings in prophylactic oophorectomy specimens in high-risk women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10689-016-9878-4

Outcome of preventive surgery and screening for breast and ovarian cancer in BRCA mutation carriers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10689-016-9878-4

Cancer Incidence in BRCA1 mutation carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10689-016-9878-4

Advances in the recognition of tubal intraepithelial carcinoma: applications to cancer screening and the pathogenesis of ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10689-016-9878-4

Microscopic and early-stage ovarian cancers in BRCA1/2 mutation carriers: building a model for early BRCA-associated tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10689-016-9878-4

Support of the 'fallopian tube hypothesis' in a prospective series of risk-reducing salpingo-oophorectomy specimens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10689-016-9878-4

Long term follow up of BRCA1 and BRCA2 mutation carriers with unsuspected neoplasia identified at risk reducing salpingo-oophorectomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10689-016-9878-4

Pathologic findings at risk-reducing salpingo-oophorectomy: primary results from Gynecologic Oncology Group Trial GOG-0199.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10689-016-9878-4

Outcome of unexpected adnexal neoplasia discovered during risk reduction salpingo-oophorectomy in women with germ-line BRCA1 or BRCA2 mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10689-016-9878-4

Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: Evidence for a causal relationship.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10689-016-9878-4

Serous tubal intraepithelial carcinoma: its potential role in primary peritoneal serous carcinoma and serous cancer prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10689-016-9878-4

TP53 mutations in serous tubal intraepithelial carcinoma and concurrent pelvic high‐grade serous carcinoma—evidence supporting the clonal relationship of the two lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10689-016-9878-4

Origin and pathogenesis of pelvic (ovarian, tubal, and primary peritoneal) serous carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10689-016-9878-4

"Primary peritoneal" high-grade serous carcinoma is very likely metastatic from serous tubal intraepithelial carcinoma: assessing the new paradigm of ovarian and pelvic serous carcinogenesis and its implications for screening for ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10689-016-9878-4

Prevalence of BRCA1 and BRCA2 germ line mutations among women with carcinoma of the fallopian tube

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10689-016-9878-4

Is uterine serous papillary carcinoma a BRCA1-related disease? Case report and review of the literature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10689-016-9878-4

BRCA germline mutations in Jewish women with uterine serous papillary carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10689-016-9878-4

The rate of the predominant Jewish mutations in the BRCA1, BRCA2, MSH2 and MSH6 genes in unselected Jewish endometrial cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10689-016-9878-4

BRCA1/2 germline mutations in Jewish patients with uterine serous carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10689-016-9878-4

BRCA1, TP53, and CHEK2 germline mutations in uterine serous carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10689-016-9878-4

Endometrial cancers in mutation carriers from hereditary breast ovarian cancer syndrome kindreds: report from the Creighton University Hereditary Cancer Registry with review of the implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10689-016-9878-4

Carcinoma of the corpus uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10689-016-9878-4

Etiologic heterogeneity in endometrial cancer: evidence from a Gynecologic Oncology Group trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10689-016-9878-4

Uterine papillary serous cancer: a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10689-016-9878-4

Clinical and pathologic characteristics of serous carcinoma confined to the endometrium: a multi-institutional study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10689-016-9878-4

Gynecologic Cancer InterGroup (GCIG) consensus review for uterine serous carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10689-016-9878-4

Coexisting intraepithelial serous carcinomas of the endometrium and fallopian tube: frequency and potential significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10689-016-9878-4

The origin of serous ovarian cancer may be found in the uterus: a novel hypothesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10689-016-9878-4

Concurrent endometrial intraepithelial carcinoma (EIC) and serous ovarian cancer: can EIC be seen as the precursor lesion?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10689-016-9878-4

Characterization of precursor lesions in the endometrium and fallopian tube epithelium of early-stage uterine serous carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10689-016-9878-4

Primary sources of pelvic serous cancer in patients with endometrial intraepithelial carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10689-016-9878-4

Müllerian precursor lesions in serous ovarian cancer patients: using the SEE-Fim and SEE-End protocol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10689-016-9878-4

Modifiers of cancer risk in BRCA1 and BRCA2 mutation carriers: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10689-016-9878-4

A comprehensive approach to the identification and management of the BRCA patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10689-016-9878-4

Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: a systematic review to update the U.S. Preventive Services Task Force recommendation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10689-016-9878-4

Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10689-016-9878-4

Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10689-016-9878-4

Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10689-016-9878-4

Risk-reducing salpingectomy as preventative strategy for pelvic serous cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10689-016-9878-4

Prophylactic bilateral salpingectomy as a prevention strategy in women at high-risk of ovarian cancer: a mini-review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10689-016-9878-4

Prophylactic salpingectomy and delayed oophorectomy as an alternative for BRCA mutation carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10689-016-9878-4

Bilateral risk-reduction mastectomy in BRCA1 and BRCA2 mutation carriers: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10689-016-9878-4

Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10689-016-9878-4

Risk-reducing surgery increases survival in BRCA1/2 mutation carriers unaffected at time of family referral

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10689-016-9878-4

Impact of oophorectomy on cancer incidence and mortality in women with a BRCA1 or BRCA2 mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10689-016-9878-4

Decision analysis--effects of prophylactic mastectomy and oophorectomy on life expectancy among women with BRCA1 or BRCA2 mutations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10689-016-9878-4

Effect of prevention strategies on survival and quality-adjusted survival of women with BRCA1/2 mutations: an updated decision analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10689-016-9878-4

Hormone replacement therapy and life expectancy after prophylactic oophorectomy in women with BRCA1/2 mutations: a decision analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10689-016-9878-4

Survival analysis of cancer risk reduction strategies for BRCA1/2 mutation carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10689-016-9878-4

A simulation model to predict the impact of prophylactic surgery and screening on the life expectancy of BRCA1 and BRCA2 mutation carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10689-016-9878-4

Acceptability of prophylactic salpingectomy with delayed oophorectomy as risk-reducing surgery among BRCA mutation carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10689-016-9878-4

Risk-reducing salpingectomy with delayed oophorectomy in BRCA1/2 mutation carriers: patients' and professionals' perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10689-016-9878-4

Early salpingectomy (TUbectomy) with delayed oophorectomy to improve quality of life as alternative for risk-reducing salpingo-oophorectomy in BRCA1/2 mutation carriers (TUBA study): a prospective non-randomised multicentre study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10689-016-9878-4

Occult tubal carcinoma found at risk reducing salpingectomy in a BRCA1 carrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10689-016-9878-4

Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10689-016-9878-4

Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10689-016-9878-4

Hormone therapy and the risk of breast cancer in BRCA1 mutation carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10689-016-9878-4

Use of total abdominal hysterectomy and hormone replacement therapy in BRCA1 and BRCA2 mutation carriers undergoing risk-reducing salpingo-oophorectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10689-016-9878-4

Estrogen receptor status in BRCA1- and BRCA2-related breast cancer: the influence of age, grade, and histological type

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10689-016-9878-4

Histopathological features of breast tumours in BRCA1, BRCA2 and mutation-negative breast cancer families

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10689-016-9878-4

Risk factors for endometrial cancer among women with a BRCA1 or BRCA2 mutation: a case control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10689-016-9878-4

The risk of endometrial cancer in women with BRCA1 and BRCA2 mutations. A prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10689-016-9878-4

The incidence of endometrial cancer in women with BRCA1 and BRCA2 mutations: an international prospective cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10689-016-9878-4

Tamoxifen and risk of endometrial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10689-016-9878-4

Carcinoma of the cervix uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10689-016-9878-4

Clinical management of women at high risk of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10689-016-9878-4

Hormone therapy in oophorectomized BRCA1/2 mutation carriers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10689-016-9878-4

Osteoporosis risk and management in BRCA1 and BRCA2 carriers who undergo risk-reducing salpingo-oophorectomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10689-016-9878-4

The endometrial effects of SERMs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10689-016-9878-4

Update on raloxifene: mechanism of action, clinical efficacy, adverse effects, and contraindications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10689-016-9878-4

Risk of Endometrial Carcinoma Associated with BRCA Mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10689-016-9878-4

Effect of Short-Term Hormone Replacement Therapy on Breast Cancer Risk Reduction After Bilateral Prophylactic Oophorectomy in BRCA1 and BRCA2 Mutation Carriers: The PROSE Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10689-016-9878-4

Is Uterine Papillary Serous Adenocarcinoma a Manifestation of the Hereditary Breast–Ovarian Cancer Syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10689-016-9878-4

Familial papillary serous carcinoma of the cervix, peritoneum, and ovary: a report of the first case

21 January 2018

1 reference

12 December 2020

Hereditary ovarian cancer. Heterogeneity in age at onset

1 reference

12 December 2020

Germline BRCA2 mutation in a patient with fallopian tube carcinoma: a case report

1 reference

12 December 2020

Papillary serous carcinoma of the uterine cervix: a clinicopathologic study of 17 cases

1 reference

12 December 2020

Uterine serous and grade 3 endometrioid carcinomas: is there a survival difference?

1 reference

12 December 2020

Transtubal spread of endometrial carcinoma: correlation of intra-luminal tumour cells with tumour grade, peritoneal fluid cytology, and extra-uterine metastasis

1 reference

12 December 2020

Familial association of carcinoma of the breast and ovary

1 reference

12 December 2020

Expression of BRCA1 protein in benign, borderline, and malignant epithelial ovarian neoplasms and its relationship to methylation and allelic loss of the BRCA1 gene

1 reference

12 December 2020

Carcinoma of the breast and ovary in three families

1 reference

12 December 2020

Prophylactic mastectomy: an appraisal

1 reference

12 December 2020

Unexpected gynecologic neoplasms in patients with proven or suspected BRCA-1 or -2 mutations: implications for gross examination, cytology, and clinical follow-up

1 reference

12 December 2020

Hereditary ovarian cancer. Heterogeneity in age at diagnosis

1 reference

12 December 2020

Peritoneal carcinomatosis after prophylactic oophorectomy in familial ovarian cancer syndrome

1 reference

12 December 2020

BRCA germline mutations in women with uterine serous carcinoma--still a debate

1 reference

12 December 2020

Heredity and adenocarcinoma of the colon.

1 reference

12 December 2020

Decision analysis of prophylactic surgery or screening for BRCA1 mutation carriers: a more prominent role for oophorectomy

1 reference

12 December 2020

Serous EIC as an early form of uterine papillary serous carcinoma: recent progress in understanding its pathogenesis and current opinions regarding pathologic and clinical management

1 reference

12 December 2020

1 reference

12 December 2020

Familial breast-ovarian cancer locus on chromosome 17q12-q23

1 reference

12 December 2020

BRCA carriers, prophylactic salpingo-oophorectomy and menopause: clinical management considerations and recommendations

1 reference

12 December 2020

Genetic susceptibility to non-polyposis colorectal cancer

1 reference

12 December 2020

Prophylactic mastectomy for the prevention of breast cancer

1 reference

12 December 2020

A cautious view of putative precursors of serous carcinomas in the fallopian tubes of BRCA mutation carriers

1 reference

12 December 2020

Intra-abdominal carcinomatosis after prophylactic oophorectomy in ovarian-cancer-prone families

1 reference

12 December 2020

Outcome of risk-reducing salpingo-oophorectomy in BRCA carriers and women of unknown mutation status

1 reference

12 December 2020

Papillary peritoneal tumors in women

1 reference

12 December 2020

BRCA2 germline mutation in a woman with uterine serous papillary carcinoma--case report

1 reference

12 December 2020

10.1007/S10689-016-9878-4

Identifiers

DOI

1 reference

Dimensions Publication ID

5 September 2017

1015375232

0 references

1 reference